CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade 10x Genomics, Inc. - TXG CFD

55.73
7.23%
0.14
Low: 53.18
High: 56.09
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.14
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024874%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.002651%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 51.97
Open* 53.18
1-Year Change* -28.68%
Day's Range* 53.18 - 56.09
52 wk Range 23.81-83.34
Average Volume (10 days) 754.85K
Average Volume (3 months) 21.21M
Market Cap 6.00B
P/E Ratio -100.00K
Shares Outstanding 115.36M
Revenue 516.41M
EPS -1.46
Dividend (Yield %) N/A
Beta 1.74
Next Earnings Date May 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2023 55.73 3.30 6.29% 52.43 56.16 52.01
Mar 30, 2023 51.97 0.76 1.48% 51.21 52.32 51.07
Mar 29, 2023 50.69 1.41 2.86% 49.28 50.98 49.00
Mar 28, 2023 48.81 -0.45 -0.91% 49.26 49.42 48.27
Mar 27, 2023 49.70 -0.68 -1.35% 50.38 51.52 49.29
Mar 24, 2023 50.12 2.16 4.50% 47.96 50.30 47.65
Mar 23, 2023 48.97 0.03 0.06% 48.94 51.49 48.48
Mar 22, 2023 48.69 -1.39 -2.78% 50.08 51.08 48.61
Mar 21, 2023 50.03 1.83 3.80% 48.20 50.25 47.91
Mar 20, 2023 47.76 0.30 0.63% 47.46 48.56 46.76
Mar 17, 2023 48.08 -1.09 -2.22% 49.17 49.71 47.66
Mar 16, 2023 50.25 2.49 5.21% 47.76 50.90 47.60
Mar 15, 2023 48.54 1.45 3.08% 47.09 49.32 47.08
Mar 14, 2023 48.63 0.07 0.14% 48.56 49.52 48.06
Mar 13, 2023 47.44 3.47 7.89% 43.97 49.32 43.97
Mar 10, 2023 44.93 -1.55 -3.33% 46.48 46.49 43.15
Mar 9, 2023 47.00 -1.65 -3.39% 48.65 49.98 46.93
Mar 8, 2023 48.95 1.16 2.43% 47.79 49.49 47.24
Mar 7, 2023 48.16 0.10 0.21% 48.06 49.75 47.48
Mar 6, 2023 48.39 -2.30 -4.54% 50.69 50.80 48.13

10x Genomics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 516.409 490.49 298.845 245.893 146.313
Revenue 516.409 490.49 298.845 245.893 146.313
Cost of Revenue, Total 120.386 74.091 58.468 61.033 28.661
Gross Profit 396.023 416.399 240.377 184.86 117.652
Total Operating Expense 684.353 542.743 834.508 276.466 257.077
Selling/General/Admin. Expenses, Total 298.3 257.56 199.726 130.834 87.936
Research & Development 265.667 211.752 570.923 83.097 109.9
Other Operating Expenses, Total 0 -0.66 1.27 1.502 30.58
Operating Income -167.944 -52.253 -535.663 -30.573 -110.764
Interest Income (Expense), Net Non-Operating 6.171 -0.66 -0.15 -0.274 -1.385
Other, Net -0.198 -0.802 1.337 -0.186 -0.249
Net Income Before Taxes -161.971 -53.715 -534.476 -31.033 -112.398
Net Income After Taxes -166 -58.223 -542.731 -31.251 -112.485
Net Income Before Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Total Extraordinary Items
Net Income -166 -58.223 -542.731 -31.251 -112.485
Income Available to Common Excl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Income Available to Common Incl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
Diluted Net Income -166 -58.223 -542.731 -31.251 -112.485
Diluted Weighted Average Shares 113.859 110.348 101.152 96.2416 93.8497
Diluted EPS Excluding Extraordinary Items -1.45795 -0.52763 -5.36552 -0.32471 -1.19857
Diluted Normalized EPS -1.45795 -0.52763 -5.33904 -0.32471 -1.19857
Unusual Expense (Income) 0 0 4.121
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 156.232 131.072 114.609 114.496 143.53
Revenue 156.232 131.072 114.609 114.496 143.53
Cost of Revenue, Total 36.827 30.377 27.704 25.478 27.598
Gross Profit 119.405 100.695 86.905 89.018 115.932
Total Operating Expense 179.328 171.068 177.726 156.231 159.36
Selling/General/Admin. Expenses, Total 78.887 73.401 79.337 66.675 69.877
Research & Development 63.614 67.29 70.685 64.078 61.885
Unusual Expense (Income) 0 0
Other Operating Expenses, Total 0 0 0 0
Operating Income -23.096 -39.996 -63.117 -41.735 -15.83
Interest Income (Expense), Net Non-Operating 2.69 1.911 1.129 0.441 -0.168
Other, Net 3.995 -1.95 -1.843 -0.4 0.005
Net Income Before Taxes -16.411 -40.035 -63.831 -41.694 -15.993
Net Income After Taxes -17.215 -41.914 -64.458 -42.413 -18.449
Net Income Before Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
Net Income -17.215 -41.914 -64.458 -42.413 -18.449
Income Available to Common Excl. Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
Income Available to Common Incl. Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
Diluted Net Income -17.215 -41.914 -64.458 -42.413 -18.449
Diluted Weighted Average Shares 114.767 114.112 113.575 112.966 111.913
Diluted EPS Excluding Extraordinary Items -0.15 -0.3673 -0.56754 -0.37545 -0.16485
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.15 -0.3673 -0.56754 -0.37545 -0.16485
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 747.591 774.366 480.84 106.236 68.107
Cash and Short Term Investments 587.447 663.603 424.166 65.08 47.857
Cash & Equivalents 587.447 663.603 424.166 65.08 47.857
Total Receivables, Net 85.254 51.208 33.371 29.566 13.341
Accounts Receivable - Trade, Net 85.254 51.208 33.371 28.088 13.341
Total Inventory 59.966 29.959 15.27 8.57 4.838
Prepaid Expenses 13.896 13.029 8.033 3.02 2.071
Total Assets 1018.83 929.341 605.923 124.31 75.609
Property/Plant/Equipment, Total - Net 230.41 119.823 48.821 11.127 6.925
Property/Plant/Equipment, Total - Gross 279.431 150.325 67.876 25.21 17.958
Accumulated Depreciation, Total -49.021 -30.502 -19.055 -14.083 -11.033
Other Long Term Assets, Total 10.917 12.798 76.262 6.947 0.577
Total Current Liabilities 110.357 118.126 63.049 32.362 22.141
Accounts Payable 17.351 4.709 13.028 8.792 5.443
Accrued Expenses 75.821 92.326 30.035 12.118 8.959
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 9.882 4.187 4.224
Other Current Liabilities, Total 17.185 21.091 10.104 7.265 3.515
Total Liabilities 201.258 190.269 185.84 101.053 29.704
Total Long Term Debt 0 0 19.837 25.489 6.335
Long Term Debt 0 19.837 25.489 6.335
Other Liabilities, Total 90.901 72.143 102.954 43.202 1.228
Total Equity 817.568 739.072 420.083 23.257 45.905
Redeemable Preferred Stock 0 243.244 158.414
Common Stock 0.002 0.002 0.002 0.001 0.001
Additional Paid-In Capital 1680.86 1544.22 682.494 11.165 6.136
Retained Earnings (Accumulated Deficit) -863.321 -805.098 -262.367 -231.116 -118.631
Other Equity, Total 0.022 -0.05 -0.046 -0.037 -0.015
Total Liabilities & Shareholders’ Equity 1018.83 929.341 605.923 124.31 75.609
Total Common Shares Outstanding 112.515 108.486 96.2416 93.8497 93.8497
Other Current Assets, Total 1.028 16.567
Intangibles, Net 25.397 22.354
Goodwill, Net 4.511
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 697.335 747.591 744.104 757.174 745.716
Cash and Short Term Investments 539.323 587.447 600.44 621.958 617.195
Cash & Equivalents 312.487 587.447 600.44 621.958 617.195
Total Receivables, Net 76.526 85.254 78.43 59.68 57.408
Accounts Receivable - Trade, Net 76.526 85.254 78.43 59.68 57.408
Total Inventory 63.697 59.966 51.141 44.087 38.507
Prepaid Expenses 17.762 13.896 14.065 13.298 14.442
Other Current Assets, Total 0.027 1.028 0.028 18.151 18.164
Total Assets 1003.25 1018.83 990.572 977.579 954.033
Property/Plant/Equipment, Total - Net 265.88 230.41 203.304 176.454 163.666
Property/Plant/Equipment, Total - Gross 279.431 247.698 215.665 198.415
Accumulated Depreciation, Total -49.021 -44.394 -39.211 -34.749
Goodwill, Net 4.511 4.511 4.511 4.511 4.511
Intangibles, Net 24.764 25.397 26.041 26.693 27.342
Other Long Term Assets, Total 10.761 10.917 12.612 12.747 12.798
Total Current Liabilities 94.446 110.357 100.375 113.126 120.549
Accounts Payable 18.956 17.351 17.037 16.181 15.578
Accrued Expenses 59.913 75.821 69.92 85.598 95.307
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 15.577 17.185 13.418 11.347 9.664
Total Liabilities 196.566 201.258 190.351 192.993 201.573
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0
Other Liabilities, Total 102.12 90.901 89.976 79.867 81.024
Total Equity 806.685 817.568 800.221 784.586 752.46
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 1714.86 1680.86 1644.9 1612.23 1569.06
Retained Earnings (Accumulated Deficit) -905.734 -863.321 -844.872 -827.701 -816.649
Other Equity, Total -2.443 0.022 0.194 0.058 0.048
Total Liabilities & Shareholders’ Equity 1003.25 1018.83 990.572 977.579 954.033
Total Common Shares Outstanding 113.276 112.515 111.537 110.74 109.589
Short Term Investments 226.836
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -166 -58.223 -542.731 -31.251 -112.485
Cash From Operating Activities -33.606 -21.373 -217.898 34.627 -76.409
Cash From Operating Activities 25.368 21.118 14.012 7.066 3.905
Non-Cash Items 146.443 103.177 361.202 14.048 4.156
Cash Taxes Paid 3.925 8.66 0.28 -0.022 -0.006
Cash Interest Paid 0.841 1.222 1.67 2.25 1.824
Changes in Working Capital -39.417 -87.445 -50.381 44.764 28.015
Cash From Investing Activities -350.887 -106.729 -38.394 -42.767 -6.709
Capital Expenditures -131.661 -101.278 -38.394 -42.767 -6.709
Cash From Financing Activities 15.817 35.297 468.906 414.59 105.367
Financing Cash Flow Items -5.409 -5.028 -5.848 0
Issuance (Retirement) of Stock, Net 21.226 40.325 506.01 414.59 86.628
Issuance (Retirement) of Debt, Net 0 0 -31.256 0 18.739
Foreign Exchange Effects -0.044 0.234 -0.463 -0.045 -0.018
Net Change in Cash -368.72 -92.571 212.151 406.405 22.231
Other Investing Cash Flow Items, Total -219.226 -5.451
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -166 -148.785 -106.871 -42.413 -58.223
Cash From Operating Activities -33.606 -47.329 -37.765 -20.802 -21.373
Cash From Operating Activities 25.368 18.847 12.691 6.191 21.118
Non-Cash Items 146.443 102.681 66.548 28.014 103.177
Cash Taxes Paid 3.925 3.649 3.319 2.9 8.66
Cash Interest Paid 0.841 0.841 0.841 0.841 1.222
Changes in Working Capital -39.417 -20.072 -10.133 -12.594 -87.445
Cash From Investing Activities -350.887 -317.715 -285.085 -257.558 -106.729
Capital Expenditures -131.661 -91.927 -55.355 -28.136 -101.278
Other Investing Cash Flow Items, Total -219.226 -225.788 -229.73 -229.422 -5.451
Cash From Financing Activities 15.817 10.816 8.777 2.417 35.297
Financing Cash Flow Items -5.409 -5.409 -5.409 -5.409 -5.028
Issuance (Retirement) of Stock, Net 21.226 16.225 14.186 7.826 40.325
Issuance (Retirement) of Debt, Net 0 0
Foreign Exchange Effects -0.044 -0.295 -0.21 -0.018 0.234
Net Change in Cash -368.72 -354.523 -314.283 -275.961 -92.571
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 9.4813 9210082 -415196 2022-12-31 LOW
Baillie Gifford & Co. Investment Advisor 8.8556 8602235 158847 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.6523 8404774 145652 2022-12-31 LOW
Paladin Capital Management, LLC Investment Advisor 8.3511 8112208 0 2022-03-31
ARK Investment Management LLC Investment Advisor 4.4437 4316567 -260247 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.3422 4217954 207975 2022-12-31 LOW
Sands Capital Management, LLC Investment Advisor 3.3012 3206783 -184394 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.2549 3161803 -518131 2022-12-31 LOW
SRS Investment Management, LLC Hedge Fund 3.0939 3005427 0 2022-12-31 LOW
Generation Investment Management LLP Investment Advisor/Hedge Fund 2.6231 2548100 -57577 2022-12-31 LOW
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 2.2421 2177988 -29270 2022-12-31 LOW
Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1979 2135038 -17833 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.018 1960300 -337642 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 1.507 1463901 1108820 2022-12-31 HIGH
Brown Capital Management, LLC Investment Advisor 1.4964 1453630 -161463 2022-12-31 LOW
Foresite Capital Management, LLC Private Equity 1.3985 1358528 -1145000 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3854 1345749 -18168 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3601 1321234 63324 2022-12-31 LOW
Millennium Management LLC Hedge Fund 1.2491 1213394 999487 2022-12-31 HIGH
JP Morgan Asset Management Investment Advisor 1.2158 1180996 27291 2022-12-31 LOW

Start a global, multi-asset portfolio with an award-winning platform

Trade now Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

10x Genomics, Inc. Company profile

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Industry: Laboratory Diagnostic & Testing Substances

6230 Stoneridge Mall Road
PLEASANTON
CALIFORNIA 94588
US

Income Statement

  • Annual
  • Quarterly

News

A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

09:37, 31 March 2023
People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

Singapore's DBS has seen inflows in SVB aftermath, CEO says

DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

09:24, 31 March 2023
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

US STOCKS-Futures muted as investors await key inflation data

U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

09:16, 31 March 2023
A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

09:14, 31 March 2023
A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

Coal India surpasses annual output target for first time in 17 years

Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

09:13, 31 March 2023
A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

Global IPOs marred by banks and recession enjoy few bright spots

A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

09:06, 31 March 2023
A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

UniCredit shareholders gather to vote on CEO's new pay scheme

Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

09:04, 31 March 2023

People also watch

US100

13,186.80 Price
+1.680% 1D Chg, %
Long position overnight fee -0.0249%
Short position overnight fee 0.0027%
Overnight fee time 21:00 (UTC)
Spread 3.0

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0156%
Short position overnight fee -0.0063%
Overnight fee time 21:00 (UTC)
Spread 0.03

Natural Gas

2.20 Price
+3.540% 1D Chg, %
Long position overnight fee -0.4092%
Short position overnight fee 0.3873%
Overnight fee time 21:00 (UTC)
Spread 0.005

Gold

1,969.66 Price
-0.550% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0102%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading